Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

20051,151 citationsJournal Articlebronze Open Access

Authors

Aristotle Bamias · Hellenic Air Force

Efstathios Kastritis · National and Kapodistrian University of Athens

Christina Bamia · National and Kapodistrian University of Athens

Lia A. Moulopoulos · Hellenic Air Force

Ioannis Melakopoulos · National and Kapodistrian University of Athens

George Bozas · National and Kapodistrian University of Athens

Vassiliki Koutsoukou

Abstract

The use of bisphosphonates seems to be associated with the development of ONJ. Length of exposure seems to be the most important risk factor for this complication. The type of bisphosphonate may play a role and previous dental procedures may be a precipitating factor.

Topics & Keywords

Bone health and treatments Bone and Joint Diseases Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 23, Issue 34, pp. 8580-8587

DOI: 10.1200/jco.2005.02.8670

Field-Weighted Citation Impact: 40.91